Skip to main content
. 2012 Apr 6;7(4):e32936. doi: 10.1371/journal.pone.0032936

Figure 4. Receiver operating characteristic curve (ROC) for the overall performance of MCM-2 to predict high-grade CIN and invasive tumor.

Figure 4